Do GLP-1 medications (such as Ozempic) help you age more healthily?
For people with cardiovascular disease, kidney disease, or fatty liver disease, GLP-1 medications offer proven benefits that are also relevant at older ages. As an anti-ageing intervention in healthy people, their use is not yet supported by evidence.
GLP-1 medications such as semaglutide (Ozempic, Wegovy) are well known for diabetes and excess weight, but they do more. The strongest evidence concerns the heart and blood vessels: in people with existing cardiovascular disease, they reduce the risk of a heart attack, stroke, or death from cardiovascular disease. The evidence for the kidneys is also solid: they slow the decline in chronic kidney disease and reduce protein loss through the urine. In metabolic-dysfunction-associated fatty liver disease, multiple human studies show clear improvements in the liver tissue itself.
For the brain, the signals are encouraging, but the evidence is still preliminary. Large patient groups with diabetes or cardiovascular disease show that users of these medications develop dementia considerably less often. In animal research, the drugs also reduce inflammation in the brain. However, randomised trials in humans have not yet demonstrated that they genuinely slow cognitive decline in early Alzheimer's disease or mild memory problems. An association in large groups is therefore not the same as a proven causal effect.
There is also a prevailing idea that these medications mimic the effects of caloric restriction, one of the most thoroughly studied strategies for healthy ageing, with positive effects on insulin sensitivity, inflammation, and metabolism. Whether that actually leads to more healthy life years in humans has not yet been demonstrated. They are, however, regarded as one of the eight most promising candidates for slowing ageing, alongside agents such as metformin and NAD+ supplements.
For older adults, there are also serious caveats. Weight loss caused by these medications can take muscle mass along with it. In older adults that is a real risk: less muscle means becoming weaker, falling more often, and losing independence. A small study with twenty people aged 65 and over is under way to investigate this, but results are not yet available. Furthermore, a large Taiwanese study shows that frail older adults with diabetes respond differently from fitter older adults, both in terms of effect and safety. These medications are therefore not equally suitable for everyone over 65.
Based on three reviews and analyses (PMID 41212412, 41419667, 40550948, 40318928, 38181790, 39269759). Cardiovascular outcomes are most strongly supported by large randomised trials. Cognitive and anti-ageing effects rely largely on data from large patient groups or animal research. Effects on muscle mass and ageing in older adults have not yet been published.
Do GLP-1 medications cause suicidal thoughts?
The available research gives no indication that GLP-1 medications cause suicidal thoughts; several large studies actually point to a lower risk. If you have doubts or concerns, discuss them with your doctor.
Do you lose muscle mass when losing weight with a GLP-1 medication?
With GLP-1 medications you do indeed lose muscle mass alongside fat, but you can largely limit this by combining resistance training with adequate protein intake. If you are older or already frail, discuss this risk explicitly with your doctor before starting.
Do multivitamins help with healthy ageing?
Daily multivitamins appear to offer some protection for the memory of older adults, but for most other aspects of healthy ageing the effect is small or absent. If you have a confirmed deficiency in vitamins or minerals, supplementing is certainly worthwhile; do not regard it as a miracle remedy.
Does orforglipron, the weight-loss pill, work as well as Ozempic?
Orforglipron works well for blood sugar and weight, but in obesity it is probably less powerful than injectable Ozempic and causes side effects more often. If you want to avoid the injection pen it is a serious option, but discuss it with your doctor, because the direct comparison on weight loss is still missing.
Does creatine help prevent muscle loss with GLP-1 medications like Ozempic?
Whether creatine genuinely helps preserve muscle during GLP-1 medication use is unknown, because it has never been directly studied. Strength training and adequate protein remain the only approach with any supporting evidence.
Do GLP-1 medications help with Parkinson's disease?
GLP-1 agents are showing preliminary positive signals on motor decline in Parkinson's disease, but the studies are still too small and too short-term for a clear conclusion. If you have Parkinson's disease or diabetes and want to know whether this is relevant for you, discuss it with your neurologist.